enGene Therapeutics (ENGN) Net Cash Flow (2023 - 2026)
enGene Therapeutics (ENGN) posted Net Cash Flow of $11.2 million for fiscal Q3 2026 (quarter ended Jul 31, 2026), compared with -$24.92 million a year earlier.
Powered by 
Analysis
enGene Therapeutics (ENGN) Net Cash Flow (2023 - 2026) Analysis & Trends
For the trailing twelve months through Jul 31, 2026, Net Cash Flow at enGene Therapeutics was $8.4 million; for FY2025 (ended Oct 31, 2025), it came in at -$122.85 million.
- In prior fiscal years, enGene Therapeutics' Net Cash Flow was $91.48 million in FY2024 (+49.8%), $61.09 million in FY2023 (+497.6%) and $10.22 million in FY2022.
- Quarterly Net Cash Flow has run from a low of -$110.66 million in fiscal Q1 2025 to a high of $179.16 million in fiscal Q2 2024 over five years.
- According to Business Quant data, Net Cash Flow for the three prior fiscal quarters was -$6.79 million (Q2 2026), -$13.54 million (Q1 2026) and $17.53 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 3.72 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | -3.52 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | -2.82 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 1.53 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 757.00 Mn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | -3.94 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 1.95 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -4.43 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | -722.00 Mn |
| 10 | enGene Therapeutics | 109.41 Mn | -885.06 Mn | - | 11.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 11.20 Mn |
| Apr 30, 2026 | -6.79 Mn |
| Jan 31, 2026 | -13.54 Mn |
| Oct 31, 2025 | 17.53 Mn |
| Jul 31, 2025 | -24.92 Mn |
| Apr 30, 2025 | -4.80 Mn |
| Jan 31, 2025 | -110.66 Mn |
| Oct 31, 2024 | -84.67 Mn |
| Jul 31, 2024 | -7.13 Mn |
| Apr 30, 2024 | 179.16 Mn |
| Jan 31, 2024 | 4.12 Mn |
| Oct 31, 2023 | 43.93 Mn |
| Jul 31, 2023 | 20.10 Mn |
| Apr 30, 2023 | 3.31 Mn |
| Jan 31, 2023 | -6.25 Mn |
API Access
enGene Therapeutics Net Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-cash-flow&ticker=ENGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-cash-flow", "ticker": "ENGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-cash-flow&ticker=ENGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();